Telomir Pharmaceuticals (TELO)

Profile

Full Name

Telomir Pharmaceuticals, Inc.

Ticker Symbol

TELO

Exchange

NASDAQ

Country

United States

IPO

April 9, 2019

Indexes

Not included

Employees

1

Key Details

Price

$2.48(-0.40%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.56(-26.84% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

  • What is the ticker symbol for Telomir Pharmaceuticals?
  • Does Telomir Pharmaceuticals pay dividends?
  • What sector is Telomir Pharmaceuticals in?
  • What industry is Telomir Pharmaceuticals in?
  • What country is Telomir Pharmaceuticals based in?
  • When did Telomir Pharmaceuticals go public?
  • Is Telomir Pharmaceuticals in the S&P 500?
  • Is Telomir Pharmaceuticals in the NASDAQ 100?
  • Is Telomir Pharmaceuticals in the Dow Jones?
  • When was Telomir Pharmaceuticals's last earnings report?
  • When does Telomir Pharmaceuticals report earnings?
  • Should I buy Telomir Pharmaceuticals stock now?

What is the ticker symbol for Telomir Pharmaceuticals?

The ticker symbol for Telomir Pharmaceuticals is NASDAQ:TELO

Does Telomir Pharmaceuticals pay dividends?

No, Telomir Pharmaceuticals does not pay dividends

What sector is Telomir Pharmaceuticals in?

Telomir Pharmaceuticals is in the Healthcare sector

What industry is Telomir Pharmaceuticals in?

Telomir Pharmaceuticals is in the Biotechnology industry

What country is Telomir Pharmaceuticals based in?

Telomir Pharmaceuticals is headquartered in United States

When did Telomir Pharmaceuticals go public?

Telomir Pharmaceuticals's initial public offering (IPO) was on April 9, 2019

Is Telomir Pharmaceuticals in the S&P 500?

No, Telomir Pharmaceuticals is not included in the S&P 500 index

Is Telomir Pharmaceuticals in the NASDAQ 100?

No, Telomir Pharmaceuticals is not included in the NASDAQ 100 index

Is Telomir Pharmaceuticals in the Dow Jones?

No, Telomir Pharmaceuticals is not included in the Dow Jones index

When was Telomir Pharmaceuticals's last earnings report?

Telomir Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Telomir Pharmaceuticals report earnings?

The next expected earnings date for Telomir Pharmaceuticals is May 30, 2025

Should I buy Telomir Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page